RLFTF — MindMaze Therapeutics Holding SA
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1854078 ·
Switzerland
Last close
$0.51
Market Cap
$6.37M
52W High
$0.93
52W Low
$0.33
ADV30
3,880
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2025 | — | — | — | — | 47,987,000 | 12,500,000 | 15,354,000 |
| Dec 2024 | — | — | — | — | 53,224,000 | 15,080,000 | 16,560,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-240,222,000
Inventory
$923,000
Receivables
$1,468,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 8,417,000 | -7,906,000 | -17,119,000 | 53,224,000 | 16,560,000 | — | -2,916,000 |
| Dec 2023 | 6,033,000 | -19,778,000 | -98,181,000 | 76,390,000 | 24,162,000 | — | -17,612,000 |
| Dec 2022 | 6,081,000 | -35,474,000 | -50,790,000 | 188,798,000 | 43,381,000 | — | -24,126,000 |
| Dec 2021 | 3,321,000 | -34,611,000 | -34,705,000 | 251,618,000 | 70,088,000 | — | -35,718,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ASBP | Aspire Biopharma Holdings, Inc. | $6.57M | $5.07 | — |
| APVO | Aptevo Therapeutics Inc. | $6.09M | $4.89 | — |
| SILO | Silo Pharma, Inc. | $6.69M | $0.41 | — |
| SBFM | Sunshine Biopharma Inc. | $6.73M | $0.42 | — |
| TCRT | Alaunos Therapeutics, Inc. | $5.98M | $2.45 | — |
News headlines (Yahoo Finance, 1h cache)
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
2026-05-26 05:50 · Yahoo
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
2026-05-12 05:25 · Yahoo
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
2026-03-19 06:35 · Yahoo
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
2026-03-12 07:44 · Yahoo
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
2026-03-03 07:45 · Yahoo
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
2025-12-15 06:20 · Yahoo
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
2025-11-14 17:40 · Yahoo
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
2025-10-29 06:20 · Yahoo
Relief Therapeutics Publishes 2025 Half-Year Report
2025-08-14 05:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.